133 related articles for article (PubMed ID: 33761638)
1. Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients: An observational study.
Xie XY; Chen XM; Shi L; Liu JW
Medicine (Baltimore); 2021 Mar; 100(12):e24765. PubMed ID: 33761638
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma.
Ma W; Zhang X; Chai J; Chen P; Ren P; Gong M
Tumour Biol; 2014 Dec; 35(12):12467-72. PubMed ID: 25185654
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
Zhang C; Yao C; Li H; Wang G; He X
Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
Zhou L; Ma X; Yue J; Chen T; Wang XY; Wang ZW; Pan J; Lin Y
Cancer Biomark; 2018; 23(4):561-567. PubMed ID: 30347602
[TBL] [Abstract][Full Text] [Related]
12. The regulatory effect of has-circ-0001146/miR-26a-5p/MNAT1 network on the proliferation and invasion of osteosarcoma.
Wang J; Ni J; Song D; Ding M; Huang J; Li W; He G
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32453410
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
[TBL] [Abstract][Full Text] [Related]
14. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
Li X; Yang H; Tian Q; Liu Y; Weng Y
Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
18. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
Yuan J; Chen L; Chen X; Sun W; Zhou X
J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
Mu Y; Zhang H; Che L; Li K
Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]